Prosecution Insights
Last updated: October 01, 2026

Examiner: DELLA, JAYMI E

Tech Center 3700 • Art Units: 3739 3783 3794

This examiner grants 69% of resolved cases

Analysis

Jaymi E. Della is an examiner in Tech Center 3700 and Art Unit 3739 with 844 resolved cases. The data shows an allowance rate of 68.8 percent for these matters. This 68.8 percent rate provides a baseline for applicants evaluating their chances of success during prosecution. The median days to allowance is 1518, which defines the expected timeline for reaching a grant.

An interview lift of 29.9 percent is a significant factor for strategy development. This 29.9 percent increase suggests that engaging directly with the examiner is more likely to result in an allowance than relying solely on written responses. Given the 1518 median days to allowance, an early interview might be used to address rejections before the timeline extends further.

With 844 resolved cases, the statistical trends for this examiner are well-established. The allowance rate and the 29.9 percent interview lift together indicate that while the majority of cases are allowed, the interview process is a particularly effective tool. Practitioners should prepare for a 1518-day process while utilizing the lift to improve their outcomes.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

68.8%
Allow Rate
-1.2% vs TC avg
891
Total Applications
+29.9%
Interview Lift
1518
Avg Prosecution Days
Based on 844 resolved cases, 2023–2026

Rejection Statute Breakdown

3.7%
§101 Eligibility
15.8%
§102 Novelty
37.1%
§103 Obviousness
27.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18655445 MICROWAVE ABLATION SYSTEM Non-Final OA Covidien LP
18798203 MAPPING AND TRANSSEPTAL PUNCTURE CATHETER Non-Final OA Boston Scientific Scimed, Inc.
18664140 METHODS AND APPARATUS FOR SELECTIVE TISSUE ABLATION Non-Final OA Boston Scientific Scimed, Inc.
18664163 METHODS AND APPARATUS FOR SELECTIVE TISSUE ABLATION Non-Final OA Boston Scientific Scimed, Inc.
17774275 MEDICAL SYSTEMS FOR ABLATING TISSUE Non-Final OA Boston Scientific Scimed, Inc.
18881692 ABLATION CATHETERS TO TREAT VARICOSE VEINS Non-Final OA Boston Scientific Medical Device Limited
17131020 SURGICAL INSTRUMENT WITH SENSOR AND POWERED CONTROL Final Rejection Cilag GmbH International
18259051 SYSTEMS AND METHODS FOR TEMPERATURE CONTROL IN DELIVERY OF THERMAL LIQUID TREATMENT Final Rejection INTUITIVE SURGICAL OPERATIONS, INC.
18471677 METHOD AND SYSTEM OF CONTROL OF CONDUCTIVE FLUID DURING COAGULATION Non-Final OA Smith & Nephew Asia Pacific Pte. Limited
18959187 IRRIGATED ELECTROPHYSIOLOGY BALLOON CATHETER Non-Final OA BIOSENSE WEBSTER (ISRAEL) LTD.
18755774 IRREVERSIBLE-ELECTROPORATION (IRE) BALLOON CATHETER WITH MEMBRANE-INSULATED HIGH-VOLTAGE BALLOON WIRES Non-Final OA BIOSENSE WEBSTER (ISRAEL) LTD.
18677713 BASKET CATHETER WITH MUSHROOM SHAPE DISTAL TIP Non-Final OA Biosense Webster (Israel) Ltd.
18458478 CATHETER, SYSTEM AND METHOD FOR COMBINED ABLATION MODALITIES Non-Final OA Biosense Webster (Israel) Ltd.
17980015 PULSE GENERATOR FOR IRREVERSIBLE ELECTROPORATION Final Rejection Biosense Webster (Israel) Ltd.
17825073 TRANSSEPTAL TISSUE PUNCTURE APPARATUSES, SYSTEMS, AND METHODS Final Rejection BIOSENSE WEBSTER (ISRAEL) LTD.
16950764 CATHETER WITH STAGGERED ELECTRODES SPINE ASSEMBLY Non-Final OA BIOSENSE WEBSTER (ISRAEL) LTD.
17006667 Proximal Electrode Cooling Final Rejection Biosense Webster (Israel) Ltd.
18385728 BIPOLAR SPHINCTEROTOME Final Rejection Cook Medical Technologies LLC
18385698 BIPOLAR SPHINCTEROTOME Non-Final OA Cook Medical Technologies LLC
18497767 BIPOLAR SPHINCTEROTOME Non-Final OA Cook Medical Technologies LLC
18779373 MULTI-POLE SYNCHRONOUS PULMONARY ARTERY RADIOFREQUENCY ABLATION CATHETER Non-Final OA PULNOVO MEDICAL INC.
18402260 SYSTEMS AND METHODS SYSTEMS RELATED TO ELECTROSURGICAL WANDS WITH SCREEN ELECTRODES Final Rejection ArthroCare Corporation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month